| Date Filed | Type | Description |
| 08/03/2023 |
4
| Lawley Lori D (CFO) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Paid exercise price by delivering 229 shares
@ $3.28, valued at
$751.1 |
|
| 04/04/2023 |
4
| Lawley Lori D (CFO) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Paid exercise price by delivering 274 shares
@ $3.31, valued at
$906.9 |
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2022 |
4
| Lawley Lori D (CFO) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Paid exercise price by delivering 229 shares
@ $8.17, valued at
$1.9k
|
|
| 04/05/2022 |
4
| Lawley Lori D (CFO) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Paid exercise price by delivering 274 shares
@ $9.23, valued at
$2.5k
|
|
| 08/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2020 |
4
| Lawley Lori D (Principal Accounting Officer) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Granted 4,500 shares
@ $0
Granted 25,000 options to buy
@ $7.87, valued at
$196.8k
|
|
| 08/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2019 |
4
| Lawley Lori D (Principal Accounting Officer) has filed a Form 4 on NEWLINK GENETICS CORP|
Txns:
| Granted 50,000 options to buy
@ $1.8, valued at
$90k
|
|
| 02/14/2019 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 08/03/2018 |
3
| Lawley Lori D (Principal Accounting Officer) has filed a Form 3 on NEWLINK GENETICS CORP |